Published in Medical Devices and Surgical Technology Week, March 14th, 2004
Scientists in Denmark developed "a method for the preparation of autologous fibrin glue with platelet growth factors," and described "its use with particulate cancellous bone in reconstructive maxillofacial surgery."
"The fibrin glue is a two-component glue, where the one component is a concentrated fibrinogen solution with platelet growth factors and the other component is a thrombin solution," explained J.J. Thorn and coauthors at the University of Copenhagen. "Both components were produced from the patients own blood, thus making the glue entirely...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.